Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

BACKGROUND: To explore the efficacy and safety of switching from once-daily basal insulin therapy to once-daily pre-meal injection insulin degludec/insulin aspart (IDegAsp) with respect to the glycemic control of participants with type 2 diabetes mellitus (T2DM). METHODS: In this multicenter, open-l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Cho, Kyu Yong, Nakamura, Akinobu, Oba-Yamamoto, Chiho, Tsuchida, Kazuhisa, Yanagiya, Shingo, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7453982/
https://ncbi.nlm.nih.gov/pubmed/31769240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2019.0093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados